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Abstract 
Background: Coagulation cascades are activated during Cardiopulmonary 
Bypass (CPB) and their proper monitoring and maintenance determine the 
outcomes of operation to a big extent. Here, we assessed serum fibrinogen and 
Fibrin Degradation Products (FDP) in adult patients undergoing CABG with 
using CPB, either with hypothermia or normothermia.  
Materials and Methods: In a cross-sectional study, 80 adult patients’ 
candidate for elective CABG were randomly assigned into two groups: 
hypothermia and normothermia to assess fibrinogen and FDP, perioperatively. 
Results: Patients included 32 men (80%) in the hypothermia group and 26 
men (60%) in the normothermia with the mean age of 61.43 ± 12.64 years. 
The mean temperature in the hypothermia group was 32.33 ± 1.44 and 35.33 
± 0.71 in the normothermic group. Differences in fibrinogen levels between 
the two groups were not significant (Fib before CPB, P=0.893, and Fib after 
declamping, P=0.057). The serum level of FDP before and during CPB was 
not significantly different in hypothermia and normothermia groups 
(P=0.412, P=0.778, respectively).  
Conclusion: During cardiac surgery in hypothermia and normothermia 
conditions rate of fibrinogen decreased 25% after declamping in each group; 
this decrease seems to be due to hemodilution. FDP levels were similar in both 
groups.  
Keywords: Fibrinogen, Fibrin Degradation Products, Hypothermia, 
Cardiopulmonary bypass 
 
Please cite this article as: Ghasemzade B, Ghodrati M, Kachuian N, Banakar Y, Gorjipour 
F, Zarei AA, et al. Fibrinogen and Fibrin Degradation Products’ Levels in Cardiopulmonary 





The cardiopulmonary system is related to homeostasis 
through an interconnected network of signaling 
pathways controlling its function and regulating the 
balance between inflammation and hemostasis (1-4). 
Hemolysis and fibrinolysis systems are affected by the 
beginning of the cardiopulmonary bypass (CPB), with 
the exposure of blood to the components of the circuit. 
This exposure results in the activation of clotting 
factors and immune cells and may trigger disturbances 
in bleeding and hemolysis disorder (5, 6). Fibrinogen, 
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as a fibrin precursor, is the focal factor inactivation of 
coagulation and has a dual role in platelet congregation 
and insoluble fibrin hematoma formation. According 
to recent records, decreasing plasma fibrinogen 
concentration can affect hematoma formation from 25 
to 50 percent (7, 8). There are several mechanisms for 
decreasing the concentration or function of blood 
fibrinogen during heart surgery. These mechanisms 
include activation of the molecular effectors of 
coagulation pathways through tissue damage, exposure 
of cellular compartments and platelets to the non-self 
surfaces, CPB priming, deficit replacement with 
crystalloid and colloid, and transfusion of blood 
containing low fibrinogen and coagulation factors (9) 
which results in hemodilution and decrease in the 
concentration of fibrinogen, hematocrit, and albumin 
(10). Activation of platelets and coagulation factors in 
contact with CPB circuit and surgical trauma leads to 
their consumption. This trend is shown by evaluating 
Fibrin Degradation Products (FDP) D-dimer that 
indicates the consumption of fibrinogen. Besides, the 
excessive activation of the fibrinolysis pathway causes 
fibrinogen loss (11, 12). It is still unknown which 
mechanism leads to fibrinogen decrease during 
surgery. FDP is an important indicator of bleeding after 
thrombolysis treatment (13). Fibrinogen degradation 
and FDP have a direct effect on thrombosis formation 
(14, 15) and its high level is observed after CABG in 
the absence of aprotinin (16). 
Since hypothermia can negatively affect the 
coagulopathy (17), we hypothesized that the 
hypothermia could affect the coagulation pathway 
activation in CABG patients with hypothermic and 
normothermic CPB, hence affecting the level of 
fibrinogen and Fibrin Degradation Products. The 
present study investigated the serum fibrinogen and the 
FDP changes as molecular markers of the coagulation 




Patients: This was a cross-sectional study. The study 
population consisted of adult elective patients 
undergoing coronary artery bypass graft surgery 
(CABG). Sampling was done randomly. Eighty 
patients were assigned into two groups with the method 
of block randomization with the blocks of 4 patients: 
hypothermia group and normothermia group. 
Fibrinogen was measured in 40 patients of each group 
and FDP was measured in 22 patients of each group. 
The study was conducted in line with the criteria for 
the institutional research ethics committee of the 
Shiraz University of Medical Sciences (SUMS, 
Tehran, Iran) after filling an informed consent form 
(ethical code IR.SUMS.REC.1397.375). The study 
protocol was registered with the code 
IRCT20180930041189N1 at the Iranian Registry of 
Clinical Trials (IRCT) database. 
Exclusion criteria were history of thrombosis; 
bleeding or any coagulation disorders, regular use of 
aspirin, congenital fibrinogen disorders, and drug 
abuse, and redo surgery. Data were gathered in four 
sections, demographic (age, sex, height, and weight), 
pre-operation, during operation, and post-operation.  
Pre-operation data included medicines used, 
biochemistry markers, and hematology indexes. 
Perioperative data were duration of cardiopulmonary 
bypass, surgery, and cross-clamp, amount of 
hypothermia and normothermia level, and the number 
of packed cells and blood products required. Post-
operative data were the amount of bleeding, and the 
number of packed cells and blood products used.  
Procedures: CABG surgery was performed according 
to the standard protocol of the center for these patients. 
Anesthesia induction was done with 2 µg /kg sufentanil 
and 3 mg/kg sodium thiopental and 0.1 mg/kg 
Pancuronium for all patients and was maintained with 
0.5-1% isoflurane. It was maintained with 0.1 mg/kg/h 
atracurium, 1- 2 µg/kg fentanyl, and 0.5- 1 µg/kg 
midazolam during cardiopulmonary bypass and all 
patients received 300 u/kg heparin before the bypass to 
make the activated coagulation time (ACT) over 480 
seconds. Hypothermia management, has four levels: 
mild (32–35°C), moderate (28–32°C), severe (20–
28°C), profound (<20 C). In the present study, two 
types of temperature controls were applied: mild-
hypothermia (32- 35°C) and normothermia (>35°C). 
The temperature of the heater-cooler and blanket was 
set to 30°C in the hypothermic group and 35°C in the 
normothermic group. The thermometers connected to 
the reservoir venous return measured the temperature. 
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To prime, the oxygenator in both groups, crystalloid 
(2000 mL ringer) and colloid (50 mL albumin) were 
used. During CPB, heparin was prescribed to achieve 
the target ACT. At the end of CPB and disconnecting 
from the cardiopulmonary bypass system, protamine 
sulfate of 1 mg per 100 units of heparin was 
administered to achieve the target ACT of 80 to 120 
seconds. Two mL of arterial blood samples were drawn 
from patients at two times and kept into tubes 
containing trisodium citrate. The first sample was 
taken before the injection of heparin and CPB start and 
the second one was taken before the beginning of the 
rewarming procedure in the hypothermic group and 
simultaneously with the aortic declamping in the 
normothermic group. Then, they were sent to the 
laboratory for testing fibrinogen and FDP. Clauss 
method was used to assay plasma fibrinogen according 
to the CDC and the CAP guidelines. FDP was 
measured using the human FDP ELISA kit (Production 
No: E-EL-H2194, Document number: ELAB-EK-
WPRT5HF9, Company: Elabscience) in serologic 
assessments.  
Statistical Analysis: Data were analyzed by Statistical 
Package for Social Sciences, version 14 (SPSS Inc., 
Chicago, IL, USA) on a Microsoft Windows-based 
setting. For studying correlations between variables, 
the Pearson test was used; if there were a normal data 
distribution pattern and Spearman in the absence of a 
normal distribution pattern. A paired t-test was used to 
compare a two-time normal variable. An independent 
t-test was used for variables with a normal distribution. 
A chi-square test was used for comparing frequencies 
of qualitative variables between groups. The level of 




A cross-sectional study comprising 80 patients 
undergoing coronary artery bypass graft in two groups 
was conducted. The study population consisted of 22 
female patients (27.5 %) and 58 male patients (72.5 %) 
with a mean age of (61.43±12.64) (29-82 years old). 




Figure 1. Changes Hemoglobin in 2, 6, 12, 24 hours after surgery. *P<0.05 compared with the Normothermia group at the 
same time. 
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have shown in Table 1. There were no significant 
differences in the frequency of comorbidities between 
the two groups (P>0.05). 
The mean temperature reduction in the 
hypothermia group was (3.96±1.42) and in the 
normothermia group was (1.03±0.72) (P0.001) 
(Table 2). While their mean body temperature at ICU 
entrance in the hypothermia group was (35.71±0.49) 
and in the normothermia group (36.07±0.50), 
respectively. There was no significant difference 
 
Figure 2. Changes in the pH at 2, 6, 12, and 24 hours after surgery. *P<0.05 compared with the hypothermia group at the 
same time. 
 
Table 1: Patient Characteristics (N=80; allocated to two groups; 40 in each). 
P value Hypothermia 
















0.273 63.05±11.57 60.73 ±9.38 Age (y) 
0.290 70.05 ±12.46 72.93±9.51 Weight (Kg) 
0.949 165.95 ±8.56 
 



























Digestive system disease (N) 
   *Mean (range) 
SD: Standard deviation 
N: Number 
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between groups regarding measured outcomes 
(P=0.626). 
However, time for restoration of cardiac beating 
rhythm after cross-clamp was lower in the 
normothermia group (P=0.002) (Table 2). Besides, 
cardiac rhythm in all patients was following normal 
sinus rhythm pattern, except two patients in the 
normothermia group demonstrating ventricular 
fibrillation. 
The fibrinogen level between the two groups 
was not different. However, in each group’s serum 
level of fibrinogen after declamping was decreased 
significantly compared with the before CPB time in 
both groups (P=0.001) (Table 3). 
Comparing the FDP level between both groups 
revealed no significant difference at similar time 
points; also, the serum level of FDP before and during 
CPB was not significantly different in each group 
(P=0.412 and P=0.778, respectively) (Table 4). 
The mean bleeding 24 hours after surgery is 
presented in table 2. There was no significant 
difference in both groups (P=0.717). The number of 
recipients of the packed cells was 40 (100%) in the 
hypothermia group and 34 (85%) in the normothermia 
group. Changes in blood Hemoglobin at 2, 6, 12, and 
24 hours after surgery were not significant in both 
groups (P=0.779) (Figure 1). 
Utilization of albumin, gelatin, and 
Hydroxyethyl starch) in ICU were not significantly 
different in both groups. Acidosis at 2 hours post-
operation was significantly lower in the hypothermia 
group (P=0.002) (Figure2). 
Table 2: Intraoperative and postoperative variables of patients (N=80; allocated to two groups; 40 in each). 





0.401 59.98 ±10.26 58.65±8.51 CPB Time (min) 
0.003* 38.04 ±9.11 28.23±10.12 Cross Clamp (min) 
0.002* 69.58 ±7.45  33.45±3.45  Time for restoration of cardiac beating rhythm 
(s) 
0.123 652± 256.31 645.12 ±203.27 Bleeding 24 h 
0.779 10.46± 1.19 10.28± 1.06 Hb (mg/dL) ICU 
0.657 30.48± 3.31 31.43± 2.61 Hct (%) ICU 
<0.001* 32.33± 1.44 35.35± 0.71 Temperature decrease in CPB (°C) 
   SD: Standard deviation, 
CPB: cardiopulmonary bypass 
min: minutes,  
s: second, 
h: hours  







Table 3: Comparing fibrinogen level between both groups (N=80; allocated to two groups; 40 in each). 
P Value Hypothermia 
Mean ± SD 
Normothermia 
Mean ± SD 
Variable 
0.893 357.05 ±114.72 326.23±95.65 Fibrinogen before CPB 
0.057 246.10 ±142.34 247.28±75.46 Fibrinogen after declamping of aorta 
 
 
Table 4: Comparing the FDP levels between two groups (N=80; allocated to 2 groups; 40 in each). 
P Value Hypothermia 
Mean ± SD 
Normothermia 
Mean ± SD 
Variable 
0.136 21.84±23.49 26.42±33.37 FDP before CPB 
0.492 22.35±24.89 24.02±25.40 FDP after declamping of aorta 
FDP: Fibrin Degradation Product  
One-way ANOVA: In normothermia P value:0.412 and in hypothermia P value= 0.778 
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Discussion 
At the beginning of the CPB and the exposure of the 
blood to the CPB circuit as an exogenous entity, a 
complicated interaction starts between coagulation, 
fibrinolysis, and inflammatory systems (8, 10) leading 
to coagulation disorder, over-bleeding, and systematic 
inflammatory response syndrome due to activation of 
both cellular and humoral components (8). In the 
present study, the serum levels of fibrinogen and FDP 
were compared in the hypothermia and normothermia 
in patients under CABG surgery. Differences in the 
fibrinogen and FDP level between the two groups were 
not significant before. The serum fibrinogen decreased 
by 25% after declamping in both groups. It seems this 
reduction is highly influenced by hemodilution, while 
the serum FDP changes were not observed in both 
groups.  
The mean consumption of packed cells was 
similar in both groups, wherein the hypothermia group 
all patients required transfusion, but only 24 cases were 
so in the normothermia group. It should be noted that 
the mean volume of bleeding in the first 24-hour after 
the surgery did not differ much but normothermic 
patients showed higher levels of Hemoglobin and 
Hematocrit.  
A study conducted in Italy by Solomon et al. 
in 2014 revealed that fibrinogen measurement before 
and after CPB helps in the timely intervention for 
proper hemostasis and prevention of bleeding (18). 
In a study by Kaplan et al. in 2018, patients were 
examined in two groups: hypothermia and 
normothermia. Aortic cross-clamp time, bypass time, 
waking and extubation time, duration of ICU and 
hospitalization, drainage, mean serum lactate level, 
arrhythmia, infection, renal failure, neurological 
complications, myocardial infarction, or mortality 
were the same in the two groups. Inotropic score and 
blood transfusion rates were significantly lower in the 
normothermic group than in the hypothermic group. 
They claimed that surgery is possible at the patient's 
normal body temperature and the risk from the 
lowering of the body temperature could be abstained 
(19). The results of the present study are in line with 
that except in the following items, lower acidosis in the 
hypothermic group, a significant rise of BUN in both 
groups, similar consumption of inotrope in both cases, 
and the shorter heart rhythm resuming meantime after 
the aortic decamping in the normothermic group. 
According to a retrospective study by Williams 
et al. in 2018, patients were examined based on their 
body temperature, pH disorders, and amount of blood 
transfusion. There was no relation between 
hypothermia at the end of the surgery and the amount 
of blood transfusion after that. However, pH disorders 
were associated with an increase in transfusion after 
surgery (20). The present study confirms these findings 
although we could not find a meaningful relation 
between pH disorder and transfusion increase which 
might be due to the low sample size. 
A study by Gielen et al. in 2015 compared the 
concentration of hematocrit, albumin, fibrinogen, and 
Fibrin Degradation Products (D-dimer, FDP) in 10 
patients before and after CPB. The results showed that 
the concentration of plasma fibrinogen reduced by 
30% during the surgery.  
This decrease appears to be due to 
hemodilution. There was also a reduction in hematocrit 
and albumin and no significant elevation in D-dimer 
and FDP (21). The present study showed a 25 percent 
decrease in fibrinogen level and an increase in FDP in 
the hypothermic group. 
A German study by Boldt et al. in 1996 on 
platelet function and coagulation system in CPB 
patients demonstrated that in two groups of patients 
undergoing hypothermic and normothermic CPB 
operations, hypothermia leads to more reduction in 
platelet aggregation and coagulation in hypothermic 
patients compared to normothermic ones (22). 
 
Conclusion 
Fibrinogen and FDP levels were similar in both groups 
when measured and compared at identical times. Post-
declamping fibrinogen levels decreased in both groups 
compared to the preoperative values in the same group. 
It seems that this trend is a result of the physiologic and 
pathophysiologic effects of hemodilution; though more 
widespread research; both basic and clinical are needed 
to approve the latter assumption. However, from the 
clinical perspective, normothermic CPB appears to be 
associated with faster restoration of the heart rhythm 
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